Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

The power and limitations of pharmacogenetic epidemiology.

Lapane K, Weinstock MA

Brown Medical School-Community Health, Providence, Rhode Island 02912, USA. Kate_Lapane@brown.edu

Ovid and many physicians in the thousands of years since have been stymied by the large interindividual variability in drug response and toxicity. That all patients do not reap the same benefits from the same drugs is well established. In the case of statins, estimates of effectiveness range from 30 to 70% of users (Spear et al., 2001). Disentangling why this occurs is complex, and two new disciplines are likely to make headway in furthering our understanding of these phenomena.

Published 16 July 2007 in J Invest Dermatol, 127(8): 1851-2.
Full-text of this article is available online (may require subscription).

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.